Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|5|6|503-515

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.6, 2004-08, pp. : 503-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 727-740

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 1, 2008-03 ,pp. : 24-29

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer#39;s Disease

By  

Current Neuropharmacology, Vol. 15, Iss. 4, 2017-04 ,pp. : 480-494

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic non-human animals capable of producing heterologous antibodies

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1185-1189

Informa Healthcare

Access to resources Recommend Favorite

Posttranslational Modifications as Versatile Regulators of Parkin Function

By  

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2477-2485

Bentham Science Publishers

Access to resources Recommend Favorite